🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hemophilia is an inherited bleeding disorder characterized by deficiency of...
Status
Completed
Location
Hayatabad Medical Complex
Start Date
2025-09-09
Trial ID
NCT07187661
Treatments Being Tested
This substudy will evaluate the effect of crenezumab on the longitudinal ta...
Status
Completed
Location
Grupo Neurociencias de Antioquia
Start Date
2019-06-10
Trial ID
NCT03977584
Treatments Being Tested
The purpose of this study is to evaluate the biodistribution, safety and to...
Status
Completed
Location
Invicro, a Konica Minolta company
Start Date
2020-08-11
Trial ID
NCT04394845
Treatments Being Tested
To determine objective response rates (RR) by RECIST guideline version 1.1 ...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2009-03
Trial ID
NCT00947167
Treatments Being Tested
The study aims to compare tau targeted radiotracers \[18F\]GTP1 and \[18F\]...
Status
Completed
Location
Invicro, a Konica Minolta company
Start Date
2020-10-26
Trial ID
NCT04566003
Treatments Being Tested
This is an open-label, longitudinal observational study evaluating the imag...
Status
Completed
Location
Molecular NeuroImaging
Start Date
2015-12-23
Trial ID
NCT02640092
Treatments Being Tested
This is an open label study to compare three new generation TAU radioligand...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2023-02-01
Trial ID
NCT05464368
Treatments Being Tested
This Phase II, multicenter, randomized, double-blind, placebo-controlled, p...
Status
Completed
Location
Collaborative Neuroscience Network, Inc.
Start Date
2019-01-25
Trial ID
NCT03828747
Treatments Being Tested
This was a phase II, randomized, placebo-controlled, double-blind study to ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-10-04
Trial ID
NCT03289143
Treatments Being Tested